SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-11-08 20:43
Tx date 2019-11-05
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-72,359 vol
0
Filed 2019-11-08 20:42
Tx date 2019-10-30
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,765
+3,765 vol
$1.00 each
72,359
Filed 2019-11-08 20:41
Tx date 2019-10-28
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,000
+6,000 vol
$1.00 each
68,594
Filed 2019-11-08 20:41
Tx date 2019-10-24
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,820
+6,000 vol
$0.97 each
62,594
Filed 2019-11-08 20:40
Tx date 2019-10-18
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,300
+2,500 vol
$0.92 each
56,594
Filed 2019-11-08 20:40
Tx date 2019-10-17
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,280
+6,000 vol
$0.88 each
54,094
Filed 2019-11-08 20:39
Tx date 2019-10-16
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,200.42
+6,047 vol
$0.86 each
48,094
Filed 2019-11-08 20:39
Tx date 2019-10-15
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,280
+6,000 vol
$0.88 each
42,047
Filed 2019-11-08 20:38
Tx date 2019-10-11
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,400
+6,000 vol
$0.90 each
36,047
Filed 2019-11-08 20:38
Tx date 2019-10-08
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,340
+6,000 vol
$0.89 each
30,047
Filed 2019-11-08 20:32
Tx date 2019-10-07
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,520
+6,000 vol
$0.92 each
24,047
Filed 2019-11-08 20:31
Tx date 2019-10-03
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,280
+6,000 vol
$0.88 each
18,047
Filed 2019-11-08 20:30
Tx date 2019-10-02
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,260.89
+6,047 vol
$0.87 each
12,047
Filed 2019-11-08 20:30
Tx date 2019-10-01
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,340
+6,000 vol
$0.89 each
82,829
Filed 2019-10-10 02:13
Tx date 2019-10-02
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-69,914.39
-76,829 vol
$0.91 each
0
Filed 2019-10-08 19:10
Tx date 2019-09-30
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,381.83
+6,047 vol
$0.89 each
76,829
Filed 2019-10-08 19:10
Tx date 2019-09-27
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,321.36
+6,047 vol
$0.88 each
70,782
Filed 2019-10-08 19:09
Tx date 2019-09-26
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,400
+6,000 vol
$0.90 each
64,735
Filed 2019-10-08 19:09
Tx date 2019-09-25
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,950
+5,500 vol
$0.90 each
58,735
Filed 2019-10-08 19:08
Tx date 2019-09-23
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,340
+6,000 vol
$0.89 each
53,235
Filed 2019-10-08 19:08
Tx date 2019-09-20
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,442.30
+6,047 vol
$0.90 each
47,235
Filed 2019-10-08 19:07
Tx date 2019-09-19
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,400
+6,000 vol
$0.90 each
41,188
Filed 2019-10-08 19:07
Tx date 2019-09-18
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,380
+1,500 vol
$0.92 each
35,188
Filed 2019-10-08 19:06
Tx date 2019-09-17
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,684.18
+6,047 vol
$0.94 each
33,688
Filed 2019-10-08 19:06
Tx date 2019-09-13
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,744.65
+6,047 vol
$0.95 each
27,641
Filed 2019-10-08 19:05
Tx date 2019-09-12
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,744.65
+6,047 vol
$0.95 each
21,594
Filed 2019-10-08 19:04
Tx date 2019-09-09
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,381.83
+6,047 vol
$0.89 each
15,547
Filed 2019-10-08 19:04
Tx date 2019-09-05
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,400
+6,000 vol
$0.90 each
9,500
Filed 2019-10-08 19:03
Tx date 2019-09-04
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,285.10
+3,500 vol
$0.94 each
3,500
Filed 2019-09-09 02:47
Tx date 2019-09-04
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-90,047 vol
0
Filed 2019-09-09 02:43
Tx date 2019-08-29
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,550
+5,000 vol
$0.91 each
90,047
Filed 2019-09-09 02:41
Tx date 2019-08-28
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,400
+6,000 vol
$0.90 each
85,047
Filed 2019-09-09 02:38
Tx date 2019-08-27
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,310
+6,000 vol
$0.89 each
79,047
Filed 2019-09-09 02:35
Tx date 2019-08-26
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,960
+8,000 vol
$0.87 each
73,047
Filed 2019-09-09 02:34
Tx date 2019-08-21
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,800
+6,000 vol
$0.80 each
65,047
Filed 2019-09-09 02:30
Tx date 2019-08-20
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,837.60
+6,047 vol
$0.80 each
59,047
Filed 2019-09-09 02:29
Tx date 2019-08-19
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,160
+6,000 vol
$0.86 each
53,000
Filed 2019-09-09 02:26
Tx date 2019-08-16
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,220
+6,000 vol
$0.87 each
47,000
Filed 2019-09-09 02:23
Tx date 2019-08-15
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,610
+6,000 vol
$0.94 each
41,000
Filed 2019-09-09 02:18
Tx date 2019-08-14
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,910
+3,000 vol
$0.97 each
35,000
Filed 2019-09-09 02:17
Tx date 2019-08-13
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,850
+6,000 vol
$0.97 each
32,000
Filed 2019-09-09 02:13
Tx date 2019-08-12
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,970
+3,000 vol
$0.99 each
26,000
Filed 2019-09-09 02:10
Tx date 2019-08-07
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,910
+6,000 vol
$0.98 each
23,000
Filed 2019-09-09 02:04
Tx date 2019-08-02
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,950
+5,000 vol
$0.99 each
17,000
Filed 2019-09-09 02:00
Tx date 2019-08-01
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,880
+6,000 vol
$0.98 each
12,000
Filed 2019-08-12 19:58
Tx date 2019-08-08
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-22,000
-20,000 vol
$1.10 each
1,935,489
Filed 2019-08-10 01:28
Tx date 2019-07-31
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-34,641 vol
6,000
Filed 2019-08-10 01:26
Tx date 2019-07-30
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,000
+6,000 vol
$1.00 each
40,641
Filed 2019-08-10 01:25
Tx date 2019-07-12
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,850
+3,000 vol
$0.95 each
34,641
Filed 2019-08-10 01:24
Tx date 2019-07-11
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,280
+6,000 vol
$0.88 each
31,641
Filed 2019-08-10 01:23
Tx date 2019-07-10
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,400
+6,000 vol
$0.90 each
25,641
Filed 2019-08-10 01:22
Tx date 2019-07-09
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,502.77
+6,047 vol
$0.91 each
19,641
Filed 2019-08-10 01:21
Tx date 2019-07-08
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,381.83
+6,047 vol
$0.89 each
13,594
Filed 2019-08-10 01:20
Tx date 2019-07-05
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,215
+1,500 vol
$0.81 each
7,547
Filed 2019-08-10 01:19
Tx date 2019-07-04
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,777.13
+6,047 vol
$0.79 each
6,047
Filed 2019-08-10 01:17
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-05 14:11
Tx date 2019-08-02
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-750,000
-750,000 vol
$1.00 each
1,955,489
Filed 2019-07-26 14:14
Tx date 2019-07-24
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-18,551.79
-17,100 vol
$1.08 each
2,705,489
Filed 2019-07-26 14:13
Tx date 2019-07-24
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-21,090
-20,000 vol
$1.05 each
2,722,589
Filed 2019-07-23 21:07
Tx date 2019-07-23
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,250
-5,000 vol
$1.05 each
2,742,589
Filed 2019-07-19 16:44
Tx date 2019-07-17
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,390.01
-2,100 vol
$1.14 each
2,747,589
Filed 2019-07-19 16:43
Tx date 2019-07-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-29,692.50
-25,000 vol
$1.19 each
2,749,689
Filed 2019-07-19 16:42
Tx date 2019-07-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-11,800
-10,000 vol
$1.18 each
2,774,689
Filed 2019-07-19 16:41
Tx date 2019-07-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-22,950
-20,000 vol
$1.15 each
2,784,689
Filed 2019-07-19 16:40
Tx date 2019-07-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-11,300
-10,000 vol
$1.13 each
2,804,689
Filed 2019-07-19 16:38
Tx date 2019-07-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,925
-10,000 vol
$1.09 each
2,814,689
Filed 2019-07-19 16:36
Tx date 2019-07-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-11,300
-10,000 vol
$1.13 each
Filed 2019-07-19 16:22
Tx date 2019-07-15
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-10,800
-10,000 vol
$1.08 each
2,824,689
Filed 2019-05-25 18:53
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$31,200
+40,000 vol
$0.78 each
40,000
Filed 2019-05-25 18:52
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
57,730
Filed 2019-05-25 18:51
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,600
+20,000 vol
$0.78 each
20,000
Filed 2019-05-25 18:49
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
177,446
Filed 2019-05-25 18:47
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
54,653
Filed 2019-05-25 18:46
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
750,946
Filed 2019-05-25 18:44
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
54,653
Filed 2019-05-24 16:28
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$31,200
+40,000 vol
$0.78 each
Filed 2019-05-24 16:23
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,600
+20,000 vol
$0.78 each
Filed 2019-05-24 16:13
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 16:09
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 16:07
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 16:04
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 16:00
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 16:28
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$31,200
+40,000 vol
$0.78 each
40,000
Filed 2019-05-24 16:27
Tx date 2019-05-01
$CTX
Crescita Therapeutics Inc.
Colas, Jean
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-24 16:23
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,600
+20,000 vol
$0.78 each
20,000
Filed 2019-05-24 16:21
Tx date 2019-05-14
$CTX
Crescita Therapeutics Inc.
Tremblay, Jean-François
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-24 16:13
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
57,730
Filed 2019-05-24 16:09
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
177,446
Filed 2019-05-24 16:07
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
54,653
Filed 2019-05-24 16:04
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
750,946
Filed 2019-05-24 16:00
Tx date 2019-05-21
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$7,800
+10,000 vol
$0.78 each
54,653
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
167,446
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
205,000
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
105,000
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
44,653
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
47,730
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+80,000 vol
210,000
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
47,730
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+35,000 vol
75,000
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
44,653
Filed 2019-01-08
Tx date 2019-01-04
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+200,000 vol
450,000
Filed 2019-01-03
Tx date 2019-01-03
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-17,195 vol
0
Filed 2019-01-03
Tx date 2019-01-03
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-17,195 vol
0
Filed 2018-06-22
Tx date 2018-06-15
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-4,811.625
-11,250 vol
$0.4277 each
180,000
Filed 2018-06-22
Tx date 2018-06-15
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$4,811.63
+11,250 vol
$0.4277 each
39,384
Filed 2018-05-30
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
Common Shares
57 - Exercise of rights
$20,499.87
+38,679 vol
$0.53 each
124,879
Filed 2018-05-30
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
Rights Crescita Rights Offering
57 - Exercise of rights
$-40,999.74
-77,358 vol
$0.53 each
0
Filed 2018-05-30
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
Rights Crescita Rights Offering
56 - Grant of rights

+77,358 vol
77,358
Filed 2018-05-30
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-05-15
Tx date 2018-05-14
$CTX
Crescita Therapeutics Inc.
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
40,000
Filed 2018-05-15
Tx date 2018-05-01
$CTX
Crescita Therapeutics Inc.
Villeneuve, Isabelle
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-05-09
Tx date 2018-05-06
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,688 vol
34,653
Filed 2018-05-09
Tx date 2018-05-09
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,688 vol
34,653
Filed 2018-04-12
Tx date 2018-04-06
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,600
+20,000 vol
$0.48 each
117,132
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
37,341
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+180,000 vol
250,000
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
37,730
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
37,730
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
157,446
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
191,250
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
80,000
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
37,341
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+80,000 vol
130,000
Filed 2018-04-06
Tx date 2018-04-03
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
740,946
Filed 2018-03-29
Tx date 2017-12-06
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
Filed 2018-03-29
Tx date 2017-12-06
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
Filed 2018-03-29
Tx date 2017-11-07
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
147,446
Filed 2018-03-29
Tx date 2017-12-06
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
Filed 2018-03-29
Tx date 2017-11-07
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
730,946
Filed 2018-03-16
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Holder: Spousal TFSA (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$224,106.26
+422,842 vol
$0.53 each
645,999
Filed 2018-03-16
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
Common Shares
57 - Exercise of rights
$20,561.35
+38,795 vol
$0.53 each
38,795
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
57 - Exercise of rights
$5,499.81
+10,377 vol
$0.53 each
119,577
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+514,028 vol
514,028
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-500,334.84
-944,028 vol
$0.53 each
0
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$19,999.55
+37,735 vol
$0.53 each
95,427
Filed 2018-03-16
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+75,470 vol
75,470
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-39,999.10
-75,470 vol
$0.53 each
0
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$52,765.74
+99,558 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$52,765.74
+99,558 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$52,765.74
+99,558 vol
$0.53 each
100,558
Filed 2018-03-16
Tx date 2017-11-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+201,116 vol
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+201,116 vol
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+199,116 vol
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+199,116 vol
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+199,116 vol
199,116
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-106,591.48
-201,116 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-106,591.48
-201,116 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-105,531.48
-199,116 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-105,531.48
-199,116 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-105,531.48
-199,116 vol
$0.53 each
0
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$15,900
+30,000 vol
$0.53 each
74,266
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
Common Shares
57 - Exercise of rights
$407.57
+769 vol
$0.53 each
1,538
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Holder: Spousal TFSA (Control or Direction)
Common Shares
57 - Exercise of rights
$4,000.44
+7,548 vol
$0.53 each
7,548
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
57 - Exercise of rights
$3,736.50
+7,050 vol
$0.53 each
14,100
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+75,637 vol
75,637
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-40,087.61
-75,637 vol
$0.53 each
0
Filed 2018-03-16
Tx date 2017-05-24
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
57 - Exercise of rights
$51,479.96
+97,132 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
57 - Exercise of rights
$51,479.96
+97,132 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
57 - Exercise of rights
$51,479.96
+97,132 vol
$0.53 each
97,132
Filed 2018-03-16
Tx date 2017-05-24
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Rights Crescita Rights Offering
56 - Grant of rights

+194,264 vol
194,264
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Rights Crescita Rights Offering
56 - Grant of rights

+194,264 vol
388,528
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Rights Crescita Rights Offering
57 - Exercise of rights
$-102,959.92
-194,264 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Rights Crescita Rights Offering
57 - Exercise of rights
$-102,959.92
-194,264 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Rights Crescita Rights Offering
57 - Exercise of rights
$-102,959.92
-194,264 vol
$0.53 each
194,264
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
57 - Exercise of rights
$15,999.64
+30,188 vol
$0.53 each
30,188
Filed 2018-03-16
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+75,472 vol
75,472
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-40,000.16
-75,472 vol
$0.53 each
0
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,714.26
+16,442 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,714.26
+16,442 vol
$0.53 each
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$8,714.26
+16,442 vol
$0.53 each
36,681
Filed 2018-03-16
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+32,884 vol
Filed 2018-03-16
Tx date 2018-02-07
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+32,884 vol
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+32,884 vol
32,884
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights

-32,884 vol
Filed 2018-03-16
Tx date 2018-03-09
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights

-32,884 vol
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-17,428.52
-32,884 vol
$0.53 each
0
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$143,758.26
+271,242 vol
$0.53 each
649,351
Filed 2018-03-16
Tx date 2017-04-17
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+542,484 vol
542,484
Filed 2018-03-16
Tx date 2018-03-13
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-287,516.52
-542,484 vol
$0.53 each
0
Filed 2018-03-13
Tx date 2018-03-12
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights
$-799,998.96
-1,509,432 vol
$0.53 each
0
Filed 2018-03-13
Tx date 2018-03-12
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$399,999.48
+754,716 vol
$0.53 each
2,834,689
Filed 2018-03-12
Tx date 2018-03-07
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Rights Crescita Rights Offering
10 - Acquisition or disposition in the public market
$-5,705.41
-570,541 vol
$0.01 each
1,509,432
Filed 2018-03-09
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-09
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-09
Tx date 2018-02-16
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights

+2,079,973 vol
2,079,973
Filed 2018-03-09
Tx date 2018-03-08
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Crescita Rights Offering
10 - Acquisition or disposition in the public market
$4,300
+430,000 vol
$0.01 each
430,000
Filed 2018-02-21
Tx date 2018-02-20
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-7,691 vol
145,734
Filed 2018-02-12
Tx date 2018-01-22
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$710.00
+1,000 vol
$0.71 each
1,000
Filed 2018-02-12
Tx date 2017-11-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-03
Tx date 2018-01-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-39,377 vol
17,195
Filed 2018-01-03
Tx date 2018-01-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-19,248 vol
8,407
Filed 2018-01-03
Tx date 2018-01-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-39,377 vol
17,195
Filed 2017-12-14
Tx date 2017-12-13
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
50,000
Filed 2017-12-14
Tx date 2017-11-07
$CTX
Crescita Therapeutics Inc.
DaRocha, Jose
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-12-08
Tx date 2017-12-06
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
147,446
Filed 2017-12-08
Tx date 2017-12-06
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-53,846 vol
730,946
Filed 2017-12-07
Tx date 2017-12-05
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$60,088
+103,600 vol
$0.58 each
116,227
Filed 2017-12-07
Tx date 2017-12-05
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,250
+15,000 vol
$0.55 each
378,109
Filed 2017-12-07
Tx date 2017-12-05
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$159,813.78
+275,541 vol
$0.58 each
363,109
Filed 2017-12-07
Tx date 2017-12-05
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$49,996
+86,200 vol
$0.58 each
109,200
Filed 2017-12-07
Tx date 2017-12-05
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$49,996
+86,200 vol
$0.58 each
86,200
Filed 2017-12-07
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-10-11
Tx date 2017-10-06
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption

+566,471 vol
2,079,973
Filed 2017-09-18
Tx date 2017-09-13
$CTX
Crescita Therapeutics Inc.
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,930
+8,500 vol
$0.58 each
17,246
Filed 2017-09-11
Tx date 2017-09-08
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,050
+5,000 vol
$0.61 each
44,266
Filed 2017-09-06
Tx date 2017-09-01
$CTX
Crescita Therapeutics Inc.
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,280
+2,000 vol
$0.64 each
8,746
Filed 2017-08-24
Tx date 2017-08-24
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$50,000.32
+67,568 vol
$0.74 each
87,568
Filed 2017-08-17
Tx date 2017-08-14
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-293,163 vol
0
Filed 2017-08-17
Tx date 2017-08-14
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
53 - Grant of warrants

+180,000 vol
396,000
Filed 2017-08-17
Tx date 2017-08-14
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
53 - Grant of warrants

+216,000 vol
216,000
Filed 2017-07-11
Tx date 2017-07-07
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$620.00
+1,000 vol
$0.62 each
18,000
Filed 2017-07-11
Tx date 2017-07-07
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,640
+4,000 vol
$0.66 each
17,000
Filed 2017-07-11
Tx date 2017-07-07
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,100
+5,000 vol
$0.62 each
23,000
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$360.00
+500 vol
$0.72 each
16,500
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,450
+3,500 vol
$0.70 each
16,000
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$670.00
+1,000 vol
$0.67 each
12,500
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,625
+11,500 vol
$0.75 each
11,500
Filed 2017-07-04
Tx date 2017-04-17
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$750.00
+1,000 vol
$0.75 each
13,000
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,550
+7,000 vol
$0.65 each
12,000
Filed 2017-07-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-04
Tx date 2017-06-29
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,250
+5,000 vol
$0.65 each
5,000
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$990.00
+1,500 vol
$0.66 each
20,000
Filed 2017-07-04
Tx date 2017-06-30
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,300
+2,000 vol
$0.65 each
18,500
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
40,000
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+70,000 vol
70,000
Filed 2017-06-28
Tx date 2017-04-17
$CTX
Crescita Therapeutics Inc.
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+18,500 vol
27,730
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+18,500 vol
27,730
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+18,500 vol
201,292
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
169,421
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
151,250
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
40,000
Filed 2017-06-28
Tx date 2017-05-24
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+18,500 vol
27,341
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+18,500 vol
27,341
Filed 2017-06-28
Tx date 2017-06-28
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
784,792
Filed 2017-06-28
Tx date 2017-05-24
$CTX
Crescita Therapeutics Inc.
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-31
Tx date 2017-05-24
$CTX
Crescita Therapeutics Inc.
Dugal, Alain
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
32,150
Filed 2017-05-31
Tx date 2017-05-24
$CTX
Crescita Therapeutics Inc.
Bussiere, Yves
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
6,746
Filed 2017-05-05
Tx date 2017-05-05
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-1,050 vol
8,841
Filed 2017-05-05
Tx date 2017-05-05
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-1,050 vol
8,841
Filed 2017-02-16
Tx date 2017-02-09
$CTX
Crescita Therapeutics Inc.
Kanji, Muneerah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-16
Tx date 2017-02-09
$CTX
Crescita Therapeutics Inc.
Kanji, Muneerah
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-04
Tx date 2017-01-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
$-76,269.30
-64,635 vol
$1.18 each
73,765
Filed 2017-01-04
Tx date 2017-01-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
$-37,282.10
-31,595 vol
$1.18 each
27,655
Filed 2017-01-04
Tx date 2017-01-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-8,404 vol
59,250
Filed 2017-01-04
Tx date 2017-01-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-17,193 vol
56,572
Filed 2017-01-04
Tx date 2017-01-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
$-76,269.30
-64,635 vol
$1.18 each
73,765
Filed 2017-01-04
Tx date 2017-01-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase

-17,193 vol
56,572
Filed 2016-10-03
Tx date 2016-09-29
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-03
Tx date 2016-09-29
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+9,230 vol
9,230
Filed 2016-10-03
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-03
Tx date 2016-09-29
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+9,230 vol
9,230
Filed 2016-09-30
Tx date 2016-09-29
$CTX
Crescita Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
13,778
Filed 2016-09-08
Tx date 2016-09-06
$CTX
Crescita Therapeutics Inc.
Laflamme, Mario
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+38,000 vol
38,000
Filed 2016-09-08
Tx date 2016-09-06
$CTX
Crescita Therapeutics Inc.
Orleski, Gregory M.C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+90,000 vol
90,000
Filed 2016-09-08
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Orleski, Gregory M.C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-08
Tx date 2016-09-06
$CTX
Crescita Therapeutics Inc.
Laflamme, Mario
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-06
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Schlader, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
20,239
Filed 2016-09-06
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Orleski, Gregory M.C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
827,690
Filed 2016-09-02
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
293,163
Filed 2016-09-02
Tx date 2016-09-01
$CTX
Crescita Therapeutics Inc.
Knight Therapeutics Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,513,502
Filed 2016-06-27
Tx date 2016-06-27
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-418 vol
9,891
Filed 2016-06-27
Tx date 2016-06-27
$CTX
Crescita Therapeutics Inc.
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-418 vol
9,891
Filed 2016-06-27
Tx date 2016-06-27
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-418 vol
9,891
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
28,134
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+103,000 vol
153,425
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
146,637
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
129,421
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
29,421
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
King-Smith, Dominic
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
15,564
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
111,250
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
Hull, Wade
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
11,250
Filed 2016-05-18
Tx date 2016-05-16
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+302,000 vol
484,792
Filed 2016-03-14
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
138,400
Filed 2016-03-14
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-14
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
138,400
Filed 2016-03-14
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
10,309
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
9,228
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Stanley, Theodore H.
4 - Director of Issuer
Holder: Stanley Research Foundation (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
18,904
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Stanley, Theodore H.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
111,127
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
67,654
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
50,425
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
871
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
8,400
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
8,465
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
138,040
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
182,792
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
London, John
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
155,786
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
78,046
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
61,637
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
1,341
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
19,652
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
72,597
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
121,860
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Guntermann, Henrich R.K.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
15,017
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
10,309
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
7,050
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
769
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
39,266
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
10,309
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Copeland, David A.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
57,692
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
138,040
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
182,792
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Lindeiner, Klaus
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
35,200
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
12,627
Filed 2016-03-04
Tx date 2016-03-01
$CTX
Crescita Therapeutics Inc.
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
223,157